525 related articles for article (PubMed ID: 26170293)
1. Cysteine cathepsins are essential in lysosomal degradation of α-synuclein.
McGlinchey RP; Lee JC
Proc Natl Acad Sci U S A; 2015 Jul; 112(30):9322-7. PubMed ID: 26170293
[TBL] [Abstract][Full Text] [Related]
2. C-terminal α-synuclein truncations are linked to cysteine cathepsin activity in Parkinson's disease.
McGlinchey RP; Lacy SM; Huffer KE; Tayebi N; Sidransky E; Lee JC
J Biol Chem; 2019 Jun; 294(25):9973-9984. PubMed ID: 31092553
[TBL] [Abstract][Full Text] [Related]
3. Loss of Cathepsin B and L Leads to Lysosomal Dysfunction, NPC-Like Cholesterol Sequestration and Accumulation of the Key Alzheimer's Proteins.
Cermak S; Kosicek M; Mladenovic-Djordjevic A; Smiljanic K; Kanazir S; Hecimovic S
PLoS One; 2016; 11(11):e0167428. PubMed ID: 27902765
[TBL] [Abstract][Full Text] [Related]
4. Lysosomal enzyme cathepsin B enhances the aggregate forming activity of exogenous α-synuclein fibrils.
Tsujimura A; Taguchi K; Watanabe Y; Tatebe H; Tokuda T; Mizuno T; Tanaka M
Neurobiol Dis; 2015 Jan; 73():244-53. PubMed ID: 25466281
[TBL] [Abstract][Full Text] [Related]
5. Taking a Bite Out of Amyloid: Mechanistic Insights into α-Synuclein Degradation by Cathepsin L.
McGlinchey RP; Dominah GA; Lee JC
Biochemistry; 2017 Aug; 56(30):3881-3884. PubMed ID: 28614652
[TBL] [Abstract][Full Text] [Related]
6. Cathepsin K is a potent disaggregase of α-synuclein fibrils.
McGlinchey RP; Lacy SM; Walker RL; Lee JC
Biochem Biophys Res Commun; 2020 Sep; 529(4):1106-1111. PubMed ID: 32819572
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin L prevents the accumulation of alpha-synuclein fibrils in the cell.
Matsuki A; Watanabe Y; Hashimoto S; Hoshino A; Matoba S
Genes Cells; 2024 Apr; 29(4):328-336. PubMed ID: 38366711
[TBL] [Abstract][Full Text] [Related]
8. Recombinant pro-CTSD (cathepsin D) enhances SNCA/α-Synuclein degradation in α-Synucleinopathy models.
Prieto Huarcaya S; Drobny A; Marques ARA; Di Spiezio A; Dobert JP; Balta D; Werner C; Rizo T; Gallwitz L; Bub S; Stojkovska I; Belur NR; Fogh J; Mazzulli JR; Xiang W; Fulzele A; Dejung M; Sauer M; Winner B; Rose-John S; Arnold P; Saftig P; Zunke F
Autophagy; 2022 May; 18(5):1127-1151. PubMed ID: 35287553
[TBL] [Abstract][Full Text] [Related]
9. The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunction.
Bellomo G; Paciotti S; Gatticchi L; Parnetti L
Mov Disord; 2020 Jan; 35(1):34-44. PubMed ID: 31729779
[TBL] [Abstract][Full Text] [Related]
10. Over-expression of an inactive mutant cathepsin D increases endogenous alpha-synuclein and cathepsin B activity in SH-SY5Y cells.
Crabtree D; Dodson M; Ouyang X; Boyer-Guittaut M; Liang Q; Ballestas ME; Fineberg N; Zhang J
J Neurochem; 2014 Mar; 128(6):950-61. PubMed ID: 24138030
[TBL] [Abstract][Full Text] [Related]
11. Double deficiency of cathepsins B and L results in massive secretome alterations and suggests a degradative cathepsin-MMP axis.
Tholen S; Biniossek ML; Gansz M; Ahrens TD; Schlimpert M; Kizhakkedathu JN; Reinheckel T; Schilling O
Cell Mol Life Sci; 2014 Mar; 71(5):899-916. PubMed ID: 23811845
[TBL] [Abstract][Full Text] [Related]
12. The role of lysosomal cathepsins in neurodegeneration: Mechanistic insights, diagnostic potential and therapeutic approaches.
Drobny A; Prieto Huarcaya S; Dobert J; Kluge A; Bunk J; Schlothauer T; Zunke F
Biochim Biophys Acta Mol Cell Res; 2022 Jul; 1869(7):119243. PubMed ID: 35217144
[TBL] [Abstract][Full Text] [Related]
13. Cellular depletion of major cathepsin proteases reveals their concerted activities for lysosomal proteolysis.
Gallwitz L; Bleibaum F; Voss M; Schweizer M; Spengler K; Winter D; Zöphel F; Müller S; Lichtenthaler S; Damme M; Saftig P
Cell Mol Life Sci; 2024 May; 81(1):227. PubMed ID: 38775843
[TBL] [Abstract][Full Text] [Related]
14. VPS35 dysfunction impairs lysosomal degradation of α-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson's disease.
Miura E; Hasegawa T; Konno M; Suzuki M; Sugeno N; Fujikake N; Geisler S; Tabuchi M; Oshima R; Kikuchi A; Baba T; Wada K; Nagai Y; Takeda A; Aoki M
Neurobiol Dis; 2014 Nov; 71():1-13. PubMed ID: 25107340
[TBL] [Abstract][Full Text] [Related]
15. Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity.
Qiao L; Hamamichi S; Caldwell KA; Caldwell GA; Yacoubian TA; Wilson S; Xie ZL; Speake LD; Parks R; Crabtree D; Liang Q; Crimmins S; Schneider L; Uchiyama Y; Iwatsubo T; Zhou Y; Peng L; Lu Y; Standaert DG; Walls KC; Shacka JJ; Roth KA; Zhang J
Mol Brain; 2008 Nov; 1():17. PubMed ID: 19021916
[TBL] [Abstract][Full Text] [Related]
16. Cathepsin D is the main lysosomal enzyme involved in the degradation of alpha-synuclein and generation of its carboxy-terminally truncated species.
Sevlever D; Jiang P; Yen SH
Biochemistry; 2008 Sep; 47(36):9678-87. PubMed ID: 18702517
[TBL] [Abstract][Full Text] [Related]
17. Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.
Chu Y; Dodiya H; Aebischer P; Olanow CW; Kordower JH
Neurobiol Dis; 2009 Sep; 35(3):385-98. PubMed ID: 19505575
[TBL] [Abstract][Full Text] [Related]
18. Saposin C, Key Regulator in the Alpha-Synuclein Degradation Mediated by Lysosome.
Ruz C; Barrero FJ; Pelegrina J; Bandrés-Ciga S; Vives F; Duran R
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233303
[TBL] [Abstract][Full Text] [Related]
19. Differential redox sensitivity of cathepsin B and L holds the key to autophagy-apoptosis interplay after Thioredoxin reductase inhibition in nutritionally stressed SH-SY5Y cells.
Nagakannan P; Eftekharpour E
Free Radic Biol Med; 2017 Jul; 108():819-831. PubMed ID: 28478025
[TBL] [Abstract][Full Text] [Related]
20. Roflupram protects against rotenone-induced neurotoxicity and facilitates α-synuclein degradation in Parkinson's disease models.
Dong WL; Zhong JH; Chen YQ; Xie JF; Qin YY; Xu JP; Cai NB; Li MF; Liu L; Wang HT
Acta Pharmacol Sin; 2021 Dec; 42(12):1991-2003. PubMed ID: 34531546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
